Pustular psoriasis and Psoriasis
Summary:
Psoriasis is found among people with Pustular psoriasis, especially for people who are female, 60+ old.
The study analyzes which people have Psoriasis with Pustular psoriasis. It is created by eHealthMe based on reports of 428 people who have Pustular psoriasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Pustular psoriasis?
Pustular psoriasis (raised bumps on the skin that are filled with pus) is found to be associated with 257 drugs and 416 conditions by eHealthMe. Check the latest studies of Pustular psoriasis.
What is Psoriasis?
Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,474 drugs and 1,695 conditions by eHealthMe. Check the latest studies of Psoriasis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
428 people who have Pustular Psoriasis and Psoriasis are studied.
Gender of people who have Pustular psoriasis and experienced Psoriasis *:
Age of people who have Pustular psoriasis and experienced Psoriasis *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Psoriasis?
- Check whether Psoriasis is associated with a drug or a conditionRelated publications that referenced our studies
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Pustular psoriasis (6,649 reports)
- Psoriasis (508,164 reports)
All the drugs that are associated with Psoriasis:
- Psoriasis (1,474 drugs)
All the conditions that are associated with Psoriasis:
- Psoriasis (1,695 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Psoriasis and Pustular psoriasis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Methotrexate and Hyperkalemia for Men aged 50-59 - 9 seconds ago
- Methotrexate and Hyperkalaemia for Men aged 50-59 - 9 seconds ago
- Methotrexate and Blood Potassium Increased for Men aged 50-59 - 9 seconds ago
- Methotrexate and Potassium - High for Men aged 50-59 - 10 seconds ago
- Methotrexate and High Potassium for Men aged 50-59 - 10 seconds ago
- Methotrexate and Elevated Potassium for Men aged 50-59 - 10 seconds ago
- Drug interactions of Etoposide and Velban - 13 seconds ago
- Gums - Swollen and drugs of ingredients of acetaminophen - 13 seconds ago
- Drug interactions of Ciprofloxacin and Albendazole - 59 seconds ago
- Vitamin C and Belbuca drug interactions for women aged 50-59 - a minute ago